Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Hepatic Encephalopathy × Glucose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Ovarian Neoplasms 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Peritoneal Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Limited Stage Small Cell Lung Cancer 1 Hepatic Encephalopathy 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

phenylacetic acid 1 ammonul 1 Sodium Benzoate 1 Glucose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00597909 2024-12-17

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Amgen

Phase 2 Terminated

Hepatic Encephalopathy, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡